Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

West Pharmaceutical Services (NY: WST )

300.52 -3.79 (-1.25%)
Official Closing Price Updated: 7:00 PM EDT, Aug 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 343,148
Open 306.84
Bid (Size) 257.80 (1)
Ask (Size) 315.54 (2)
Prev. Close 304.31
Today's Range 297.32 - 306.84
52wk Range 265.00 - 415.73
Shares Outstanding 73,500,000
Dividend Yield 0.25%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Is NYSE:WST a Good Fit for Dividend Investing?
Why WEST PHARMACEUTICAL SERVICES (NYSE:WST) qualifies as a good dividend investing stock. 
Via Chartmill
S&P 500, Nasdaq 100 Mark Seventh Straight Positive Session, Strongest Week Since October 2023: Friday's Top Movers
S&P 500 and Nasdaq 100 indices gain for seventh straight day, marking best weekly performance since October 2023 on positive economic data. SPY and QQQ close with modest daily gains while DIA has best... 
Via Benzinga
Topics Stocks
Exposures US Equities

Performance

YTD
-13.81%
-13.81%
1 Month
-4.95%
-4.95%
3 Month
-8.54%
-8.54%
6 Month
-16.50%
-16.50%
1 Year
-23.55%
-23.55%

More News

Read More
Balancing Dividends and Fundamentals: The Case of NYSE:WST.
Via Chartmill
Ford, Stellantis And Dell Are Among Top 12 Large Cap Losers Last Week (July 21-July 27): Are The Others In Your Portfolio?
Via Benzinga
Why NYSE:WST is a Top Pick for Dividend Investors.
Via Chartmill
How Is The Market Feeling About West Pharmaceutical Servs?
Via Benzinga
Uncovering Dividend Opportunities with NYSE:WST.
Via Chartmill
Why Edwards Lifesciences Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
WST Stock Earnings: West Pharmaceutical Servs Misses EPS, Misses Revenue for Q2 2024
Via InvestorPlace
Peering Into West Pharmaceutical Servs's Recent Short Interest
Via Benzinga
How Is The Market Feeling About West Pharmaceutical Servs?
Via Benzinga
Why the dividend investor may take a look at NYSE:WST.
Via Chartmill
(WST) - Analyzing West Pharmaceutical Servs's Short Interest
Via Benzinga
WST Stock Earnings: West Pharmaceutical Servs Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Exploring NYSE:WST's dividend characteristics.
Via Chartmill
3 Pharma Stocks to Sell in March Before They Crash & Burn
Via InvestorPlace
Analyzing NYSE:WST's Dividend Potential.
Via Chartmill
S&P Reclaims 5,000 As Disappointing Retail Sales Put Fed Cuts Back On Track, Small Caps Shine: What's Driving Markets Thursday?
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
(WST) - Analyzing West Pharmaceutical Servs's Short Interest
Via Benzinga
West Pharmaceutical Sets 2024 EPS Guidance at $7.50-$7.75
Via Talk Markets
Why Herbalife Shares Are Trading Lower By Around 36%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
West Pharmaceutical's 2024 Outlook Cautious, Analysts Remain Optimistic
Via Benzinga
Earnings Scheduled For February 15, 2024
Via Benzinga
Why WEST PHARMACEUTICAL SERVICES (NYSE:WST) qualifies as a quality stock.
Via Chartmill
Keybanc Maintains Overweight Rating for West Pharmaceutical Servs: Here's What You Need To Know
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.